作者:
Gomes, M. [1]
;
Tang, F. [2]
;
Chen, H. [3]
;
Cid-Ruzafa, J. [4]
;
Fenici, P. [5]
;
Khunti, K. [6]
;
Pocock, S. [7]
;
Rathmann, W. [8]
;
Shestakova, M. V. [9]
;
Surmont, F. [10]
;
Watada, H. [11]
;
Medina, J. [12]
;
Shimomura, I. [13]
;
Saraiva, G. Luporini [14]
;
Nicolucci, A.
作者单位:
AstraZeneca, Gaithersburg, MD USA
[1]
AstraZeneca, Cambridge, England
[2]
Juntendo Univ, Grad Sch Med, Tokyo, Japan
[3]
Evidera, Barcelona, Spain
[4]
AstraZeneca, Madrid, Spain
[5]
Osaka Univ, Grad Sch Med, Osaka, Japan
[6]
Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy
[7]
St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[8]
AstraZeneca, Luton, Beds, England
[9]
London Sch Hyg & Trop Med, London, England
[10]
German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany
[11]
Inst Diabet Endocrinol & Metab Dis, Endocrinol Res Ctr, Moscow, Russia
[12]
Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil
[13]
Univ Leicester, Leicester, Leics, England
[14]
发布时间
2020-08-22